1. Home
  2. FVCB vs GOSS Comparison

FVCB vs GOSS Comparison

Compare FVCB & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FVCB
  • GOSS
  • Stock Information
  • Founded
  • FVCB 2007
  • GOSS 2015
  • Country
  • FVCB United States
  • GOSS United States
  • Employees
  • FVCB N/A
  • GOSS N/A
  • Industry
  • FVCB Major Banks
  • GOSS Biotechnology: Pharmaceutical Preparations
  • Sector
  • FVCB Finance
  • GOSS Health Care
  • Exchange
  • FVCB Nasdaq
  • GOSS Nasdaq
  • Market Cap
  • FVCB 248.5M
  • GOSS 212.9M
  • IPO Year
  • FVCB N/A
  • GOSS 2019
  • Fundamental
  • Price
  • FVCB $13.30
  • GOSS $0.80
  • Analyst Decision
  • FVCB
  • GOSS Strong Buy
  • Analyst Count
  • FVCB 0
  • GOSS 5
  • Target Price
  • FVCB N/A
  • GOSS $9.20
  • AVG Volume (30 Days)
  • FVCB 14.0K
  • GOSS 2.3M
  • Earning Date
  • FVCB 01-21-2025
  • GOSS 11-07-2024
  • Dividend Yield
  • FVCB N/A
  • GOSS N/A
  • EPS Growth
  • FVCB N/A
  • GOSS N/A
  • EPS
  • FVCB 0.27
  • GOSS N/A
  • Revenue
  • FVCB $45,550,000.00
  • GOSS $105,322,000.00
  • Revenue This Year
  • FVCB N/A
  • GOSS N/A
  • Revenue Next Year
  • FVCB $14.51
  • GOSS N/A
  • P/E Ratio
  • FVCB $51.02
  • GOSS N/A
  • Revenue Growth
  • FVCB N/A
  • GOSS N/A
  • 52 Week Low
  • FVCB $9.78
  • GOSS $0.50
  • 52 Week High
  • FVCB $15.39
  • GOSS $1.60
  • Technical
  • Relative Strength Index (RSI)
  • FVCB 49.07
  • GOSS 50.75
  • Support Level
  • FVCB $13.41
  • GOSS $0.83
  • Resistance Level
  • FVCB $13.79
  • GOSS $1.10
  • Average True Range (ATR)
  • FVCB 0.37
  • GOSS 0.08
  • MACD
  • FVCB -0.06
  • GOSS 0.02
  • Stochastic Oscillator
  • FVCB 22.86
  • GOSS 31.66

About FVCB FVCBankcorp Inc.

FVCBankcorp Inc is a registered bank holding company. It operates through the sole subsidiary, FVCbank which is a community-oriented, locally-owned, and managed commercial bank. It offers commercial banking services to small and medium-sized businesses, professionals, non-profit organizations and associations, and investors. It also provides retail banking services to accommodate the individual needs of both corporate customers as well as the communities it serves. The bank provides other facilities such as online banking, mobile banking, remote deposit service, and lending products, among others. Its primary source of revenue is the net interest income.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: